PharmaBlock Forum Pushes Stage-Appropriate CMC for China Biotechs
Image
Nanjing – November 09, 2026 -- PharmaBlock hosted a two-day CMC Lifecycle Strategy Forum in Nanjing on November 5 and 6, gathering experts with senior R&D experience at AstraZeneca, AbbVie, Bayer and Pfizer to debate how stage-appropriate chemistry, manufacturing and controls (CMC) decisions can improve development efficiency.
Professionals from Seda Pharmaceutical, Jacobio Pharma, Benemae and PharmaBlock also took part. The agenda covered candidate developability, solid-state science, model-informed drug development, clinical supply and commercial manufacturing.